We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002202:SZSEGoldwind Science&Technology Co., Ltd. Analysis

Data as of 2026-05-22 - not real-time

CN¥25.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Goldwind posted exceptionally strong revenue growth in the latest quarter, driving a notable rise in earnings and boosting investor sentiment. The company trades below its discounted cash‑flow derived fair value, suggesting a modest upside, while its price‑earnings multiple sits above the sector average, indicating some valuation pressure. Technical indicators show a neutral price trend with the 20‑day moving average below the 50‑day, a bearish MACD divergence, and decreasing volume, hinting at short‑term caution near the identified support zone. Fundamentally, the firm benefits from robust top‑line expansion and a low beta, but faces high volatility, significant leverage, and moderate regulatory exposure in the Chinese renewable energy market.
Given the combination of attractive growth fundamentals, a modest valuation gap, and a sustainable dividend payout, the stock presents a nuanced risk‑return profile. Investors should weigh the upside potential against the elevated volatility and debt load, while recognizing the long‑term tailwinds in wind power and related clean‑energy initiatives.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Strong quarterly revenue and earnings momentum
  • Current price below DCF fair value
  • Technical support level offering downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated volatility and decreasing trading volume
  • High leverage relative to equity
  • Potential regulatory changes affecting renewable subsidies

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term growth tailwinds in wind and clean‑energy sectors
  • Undervalued relative to intrinsic valuation
  • Sustainable dividend with low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth63.50%
Profit Margin3.94%
P/E Ratio35.5
ROE7.36%
ROA1.59%
Debt/Equity82.52
P/B Ratio2.7
Op. Cash FlowCN¥3.6B
Free Cash FlowCN¥4.6B
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI44.1
SupportCN¥24.30
ResistanceCN¥28.99
MA 20CN¥26.42
MA 50CN¥26.76
MA 200CN¥19.90
MACDBearish
VolumeDecreasing
Fear & Greed Index91.59

Valuation

Fair ValueCN¥31.84
Target PriceCN¥26.13
Upside/Downside3.69%
GradeUndervalued
TypeBlend
Dividend Yield0.57%

Risk Assessment

Beta0.31
Volatility46.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.